What's Hot

Janet Pope Janetbirdope

3 years 6 months ago

Rx of lupus nephritis in 2022 should have LESS prednisone, MMF + one of #voclosporin or #belimumab or #obinutizumab or #tacrolimus etc. Combine #MMF with another immunesuppressant for better outcomes #EULAR2021 @RheumNow @eular_org Voclosporin sustained benefit at 2 yrs POS0681

Janet Pope Janetbirdope

3 years 6 months ago

tyk2 makes sense to inhibit in PsA. Part of kinase family including JAK/TYK2, TYK2 is ⬆️in PsA. Deficiency of TYK2 gives less autoimmune diseases. @RheumNow @eular_org #EULAR2021 BMS Tyk Talk symposium https://t.co/knP9n0Qc0u

Robert B Chao, MD doctorRBC

3 years 6 months ago

@KDAO2011 animal support is crucial to #EULAR2021 learning! https://t.co/Y1OalGcU6c

Paul Studenic Stiddyo

3 years 6 months ago

@ARD_BMJ @alessia_alunno Retrospective picture from Friday evening replacing and in honour of the #EULAR2021 congress dinner. https://t.co/jzPp1s2SZD

Md Yuzaiful Md Yusof Yuz6Yusof

3 years 6 months ago

Our Final poll results from #EULAR2021 are out. Landslide victory for #ANA to not be routinely monitored in patients treated with #TNF inhibitors or only checked when features of SLE are present @RheumNow https://t.co/4AGxHGPkco

https://twitter.com/Yuz6Yusof/status/1401192211606392836

Janet Pope Janetbirdope

3 years 6 months ago

?Counter intuitive to have ⬇️autoimmune conditions in Sero+ RA vs seronegative but could be due to other genes that are more common in seronegative ex TNF promoter gene, PTPN22 CARD15, STAT4 etc that cluster with IBD, DMType1 etc & not shared epitope POS0313 #EULAR2021 @RheumNow https://t.co/eqLCTIU7A7

https://twitter.com/drdavidliew/status/1401111639156350978

David Liew drdavidliew

3 years 6 months ago

You get more general autoimmune disease in seropos RA, right? Not compared to seroneg RA, as it so happens (incidence and point prevalence). If anything, it leans the other way - what number of things is seroneg RA, anyway? DANBIO data POS0313 #EULAR2021 @RheumNow https://t.co/mKJQ2jjCU4

Dr. John Cush RheumNow

3 years 6 months ago

Video: Psoriatic Arthritis Highlights from #EULAR2021 Dr. Jack Cush https://t.co/xedmiZKOd5 https://t.co/AShEze5rFy

https://bit.ly/3z6l7Xf

Dr. John Cush RheumNow

3 years 6 months ago

Find our #EULAR2021 psoriatic arthritis coverage in one place. https://t.co/NzB2e2Vfwb https://t.co/P8TfUxfA3F

https://bit.ly/3vQajub

Dr. John Cush RheumNow

3 years 6 months ago

Dr. Jack Cush reviews highlight presentations from Virtual #EULAR2021. https://t.co/yjId7QNRRR

https://bit.ly/3pqqdsW

Dr. John Cush RheumNow

3 years 6 months ago

Novel TYK2 Inhibitor Efficacious for Treatment of Psoriatic Arthritis by Dr. Meral K El Ramahi (@MeralElRamahiMD ) #EULAR2021 https://t.co/l6YnJvuPdi

https://bit.ly/3z5Bgwc

Dr. John Cush RheumNow

3 years 6 months ago

RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb, and Janssen. All content chosen by RheumNow & its faculty.